CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 32.46% | +1.46% | — | |
| 2 | NUVL | Nuvalent Inc-a | Stock-Other | 15.19% | — | — | |
| 3 | PHVS | Pharvaris N.V. | Stock-Other | 7.67% | +0.86% | — | |
| 4 | IRON | Disc Medicine INC | Stock-Other | 7.22% | +0.81% | NEW | |
| 5 | DNTH | Dianthus Therapeutics INC | Stock-Other | 7.22% | +0.39% | — | |
| 6 | SVRA | Savara INC | Stock-Other | 7.21% | +0.54% | +20.84% | |
| 7 | SLDB | Solid Biosciences INC | Stock-Other | 4.33% | +2.95% | +96.10% | |
| 8 | OLMA | Olema Pharmaceuticals INC | Stock-Other | 3.81% | -6.24% | -8.38% | |
| 9 | RPID | Rapid Micro Biosystems Inc-a | Stock-Other | 3.29% | -0.14% | — | |
| 10 | CDTX | Cidara Therapeutics INC | Stock-Other | 2.24% | — | — | |
| 11 | UPB | Upstream Bio INC | Stock-Other | 2.08% | -2.06% | — | |
| 12 | ANNX | Annexon INC | Stock-Other | 1.50% | +0.58% | — | |
| 13 | AVIR | Atea Pharmaceuticals INC | Stock-Other | 1.10% | +0.47% | — | |
| 14 | KYTX | Kyverna Therapeutics INC | Stock-Other | 0.96% | +0.18% | — | |
| 15 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 0.59% | — | — | |
| 16 | CABA | Cabaletta Bio INC | Stock-Other | 0.57% | +0.73% | — | |
| 17 | TNGX | Tango Therapeutics INC | Stock-Other | 0.55% | -0.44% | EXIT | |
| 18 | ✓ | Xilio Therapeutics INC | Stock-Other | 0.49% | -0.36% | EXIT | |
| 19 | ✓ | Mersana Therapeutics INC | Stock-Other | 0.44% | — | — | |
| 20 | IPSC | Century Therapeutics INC | Stock-Other | 0.38% | — | — | |
| 21 | CCCC | C4 Therapeutics INC | Stock-Other | 0.26% | +0.65% | — | |
| 22 | IVVD | Invivyd INC | Stock-Other | 0.16% | — | — | |
| 23 | NAUT | Nautilus Biotechnology INC | Stock-Other | 0.14% | — | -39.03% | |
| 24 | ✓ | Newamsterdam Pharma Company | Stock-Other | 0.13% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SVRA | Savara INC | +5.9% | +20.84% | Add |
| 2 | PHVS | Pharvaris N.V. | +3.8% | — | Add |
| 3 | ASNSUSD | X4 Pharmaceuticals INC | -0.3% | — | Add |
| 4 | NAUT | Nautilus Biotechnology INC | -1.2% | -39.03% | Trim |
| 5 | ✓ | Mersana Therapeutics INC | -2.9% | — | Add |
| 6 | ANNX | Annexon INC | -3.3% | — | Add |
| 7 | CCCC | C4 Therapeutics INC | -3.8% | — | Trim |
| 8 | AVIR | Atea Pharmaceuticals INC | -6.8% | — | Trim |
| 9 | SWTXUSD | Springworks Therapeutics INC | — | EXIT | Sold out |
| 10 | NAMS | NewAmsterdam Pharma Company N.V. | — | NEW | New buy |
| 11 | DVAX | Dynavax Technologies CORP | — | EXIT | Sold out |
| 12 | DRNAUSD | Dicerna Pharmaceuticals INC | — | EXIT | Sold out |
| 13 | ARQT | Arcutis Biotherapeutics INC | — | EXIT | Sold out |
| 14 | NUVL | Nuvalent Inc-a | — | NEW | New buy |
| 15 | IRON | Disc Medicine INC | — | NEW | New buy |
| 16 | DNTH | Dianthus Therapeutics INC | — | NEW | New buy |
| 17 | NRIX | Nurix Therapeutics INC | — | EXIT | Sold out |
| 18 | CRNX | Crinetics Pharmaceuticals In | — | EXIT | Sold out |
| 19 | SYRSEUR | Syros Pharmaceuticals INC | — | EXIT | Sold out |
| 20 | SLDB | Solid Biosciences INC | — | NEW | New buy |
| 21 | SLDB | Solid Biosciences Inc. | — | EXIT | Sold out |
| 22 | OLMA | Olema Pharmaceuticals INC | — | NEW | New buy |
| 23 | MRNS* | Marinus Pharmaceuticals INC | — | EXIT | Sold out |
| 24 | ✓ | Aptinyx INC | — | EXIT | Sold out |
| 25 | KYMR | Kymera Therapeutics INC | — | EXIT | Sold out |
| 26 | RPID | Rapid Micro Biosystems Inc-a | — | NEW | New buy |
| 27 | AGLEUSD | Aeglea Biotherapeutics INC | — | EXIT | Sold out |
| 28 | ✓ | — | EXIT | Sold out | |
| 29 | CDTX | Cidara Therapeutics INC | — | NEW | New buy |
| 30 | UPB | Upstream Bio INC | — | NEW | New buy |
| 31 | ✓ | Bctg Acquisition CORP | — | EXIT | Sold out |
| 32 | ✓ | Research Alliance CORP Ii | — | EXIT | Sold out |
| 33 | ✓ | Arya Sciences Acqu CORP Iv | — | EXIT | Sold out |
| 34 | KYTX | Kyverna Therapeutics INC | — | NEW | New buy |
| 35 | ✓ | Bcls Acquisition CORP | — | EXIT | Sold out |
| 36 | ✓ | Panacea Acquisition CORP Ii | — | EXIT | Sold out |
| 37 | ✓ | Omega Alpha Spac | — | EXIT | Sold out |
| 38 | CABA | Cabaletta Bio INC | — | NEW | New buy |
| 39 | TNGX | Tango Therapeutics INC | — | NEW | New buy |
| 40 | ✓ | Xilio Therapeutics INC | — | NEW | New buy |
| 41 | ✓ | Frazier Lifesciences Acqu Co | — | EXIT | Sold out |
| 42 | ✓ | Jiya Acquisition CORP | — | EXIT | Sold out |
| 43 | ✓ | Moonlake Immunotherapeutics | — | EXIT | Sold out |
| 44 | IPSC | Century Therapeutics INC | — | NEW | New buy |
| 45 | IVVD | Invivyd INC | — | NEW | New buy |
| 46 | ✓ | Newamsterdam Pharma Company | — | NEW | New buy |